Short commentary on ?a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking?

Multiple Sclerosis

Volumn 16, Issue 2, 2010, Pages 129-132

  Teunissen, C E ^a   Tumani, H T ^b   Bennett, J L ^c   Berven, F S ^d   Brundin, L ^e   Comabella, M ^f   Franciotta, D ^g   Federiksen, J L ^h   Fleming, J O ⁱ   Furlan, R ^j   Hintzen, R Q ^k   Hughes, S G ^l   Johnson, M H ^m   Krasulova, E ⁿ   Kuhle, J ^o   Magnone, Maria Chiara ^p   Petzold, A ^q   Rajda, C ^r   Rejdak, K ^s,t   Schmidt, H K ^u   Van Pesch, V ^v   Waubant, E ^w   Wolf, C ^x   Hemmer, B ^y   Deisenhammer, F ^z   Giovannoni, G ^aa   more..

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF BERGEN   (Norway)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^j SAN RAFFAELE HOSPITAL   (Italy)

^k ERASMUS MEDICAL CENTER   (Netherlands)

^l Medical Research   (United Kingdom)

^m LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

ⁿ CHARLES UNIVERSITY   (Czech Republic)

^o UNIVERSITY HOSPITAL BASEL   (Switzerland)

^p F HOFFMANN LA ROCHE LTD   (Switzerland)

^q UNIVERSITY COLLEGE LONDON   (United Kingdom)

^r UNIVERSITY OF SZEGED   (Hungary)

^s MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^t MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^u Accelerated Cure Project for Multiple Sclerosis   (United States)

^v UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x UCB PHARMA   (Belgium)

^y TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^z INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^aa QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

BODY FLUID; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMMUNOGLOBULIN PRODUCTION; MONITORING; MULTIPLE SCLEROSIS; NOTE; PRACTICE GUIDELINE; PROGNOSIS; STANDARDIZATION;

BIOLOGICAL MARKERS; BIOLOGICAL SPECIMEN BANKS; CONSENSUS; HUMANS; MULTIPLE SCLEROSIS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING;

EID: 76449122014     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509356368     Document Type: Note

References (7)

1. Deisenhammer F., Egg R., Giovannoni G., et al. EFNS guidelines on disease-specific CSF investigations. Eur J Neurol 2009 ; 16: 760-770.
2. Deisenhammer F., Bartos A., Egg R., et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 2006 ; 13: 913-922.
3. Bielekova B., Martin R. Development of biomarkers in multiple sclerosis. Brain 2004 ; 127: 1463-1478.
4. Teunissen CE, Dijkstra CD, Polman CH Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol 2005 ; 4: 32-41.
5. Teunissen CE, Petzold A., Bennett JL, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking, Neurology 2009 ; 73 1914-1922.
6. Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med 2006 ; 44: 750-759. (Pubitemid 43832871)
7. Jimenez CR, Koel-Simmelink MJR, Pham T., Voort van der L., Teunissen CE Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry. Proteomics Clin Appl 2007 ; 1: 1385-1392.